The ECOG-ACRIN E1910 trial

An overview of the ECOG-ACRIN E1910 trial testing blinatumomab in older patients with B-cell acute lymphoblastic leukemia who are in remission and have no measurable residual disease. It describes what the trial was testing, why it was done, what happened in the trial, what the results were, and what they mean for patients.